Figure 1: Kaplan-meier Estimation Of Proportion Of Relapses To Any Mood Event For Abilify And Placebo Groups (Abilify Image11 Figure1)
Abilify
Product Images NDC 52959-604
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Abilify (NDC 52959-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aripiprazole Chemical Structure (Abilify Structure)
Abilify 5-mg Tablets (Abilify Tab Image02 5mg)
This is a description of a medication called Abilify. The medication is in the form of blue rectangular tablets with a pill ID number of 52959-604-30. The manufacturing lot number is ABF5010Q and it was produced by OtsukaPhar in Tokyo, Japan. The medication has an expiration date of 08/12. The tablets are only available with a prescription from a doctor and the usual dosage information can be found in the insert. There is a warning on the packaging that prohibits the transfer of the medication to others and advises to keep it in a safe place.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
